Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Citi
Deloitte
Teva
McKinsey
AstraZeneca
Daiichi Sankyo
Dow
Novartis
US Army

Generated: October 18, 2017

DrugPatentWatch Database Preview

VINBLASTINE SULFATE Drug Profile

« Back to Dashboard

What is the patent landscape for Vinblastine Sulfate, and when can generic versions of Vinblastine Sulfate launch?

Vinblastine Sulfate is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, Hospira, and West-ward Pharms Int. and is included in four NDAs.

The generic ingredient in VINBLASTINE SULFATE is vinblastine sulfate. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vinblastine sulfate profile page.

Summary for Tradename: VINBLASTINE SULFATE

US Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list1
Bulk Api Vendors: see list50
Clinical Trials: see list819
Patent Applications: see list5,331
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VINBLASTINE SULFATE at DailyMed

Pharmacology for Tradename: VINBLASTINE SULFATE

Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm
VINBLASTINE SULFATE
vinblastine sulfate
INJECTABLE;INJECTION089011-001Nov 18, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
VINBLASTINE SULFATE
vinblastine sulfate
INJECTABLE;INJECTION089395-001Apr 9, 1987RXNoYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
VINBLASTINE SULFATE
vinblastine sulfate
INJECTABLE;INJECTION089515-001Apr 29, 1987RXNoYes► Subscribe► Subscribe► Subscribe
Hospira
VINBLASTINE SULFATE
vinblastine sulfate
INJECTABLE;INJECTION089565-001Aug 18, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Novartis
Harvard Business School
Healthtrust
QuintilesIMS
Dow
Cerilliant
Cantor Fitzgerald
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot